In short
Phibro Animal Health Corporation (PAHC) has revenue up 17.1% to $1.5B and net income up 106.6% to $99.7M year on year. Its net margin is 6.6% and gross margin 33.8%, and it trades at 16.2× trailing earnings. Fisclear flags 1 medium-severity risk and no high-severity ones. How we calculate this
Valuation
HealthcareLive · Yahoo FinancePrice
$33.29
$1.4B
8.3x
1.44%
52-Week Range
Decision Context
The reverse DCF implies growth expectations well above historical averages. Fundamentals need to accelerate significantly to justify the current price. Consider the margin of safety before sizing a position.
Based on filing period ending Sept 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
Fed Funds Rate
3.88%
Accommodative
10-Year Treasury
5.13%
2026-10-01
Unemployment
4.2%
Near full employment
CPI Index
336.3
2026-09-01
M2 Money Supply
$23.4T
2026-09-01
The Federal Funds rate stands at 3.88% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 5.13%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 104.0; M2 money supply is $23.4T; CPI index stands at 336.3.
SWOT Analysis — PAHC
Inflationary BoomStrengths
Net Income: $99.7M (+106.6% YoY) — Profit grew 107% — the company kept more of each dollar earned.
EPS (Diluted): $2.43 (+104.2% YoY) — Earnings per share rose 104% — each share earned more.
Gross Profit: $512.5M (+28.1% YoY) — Gross profit rose 28% — the spread between revenue and direct costs improved.
Revenue: $1.5B (+17.1% YoY) — Revenue grew 17% — the company sold more goods or services than the prior year.
Weaknesses
Operating Cash Flow: $69.0M (-13.9% YoY) — Operating cash flow fell 14% but remained positive.
Opportunities
No clear opportunities identified at this time.
Threats
Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.
Year-over-Year Changes
Net Income
$99.7M
was $48.3M
Profit grew 107% — the company kept more of each dollar earned.
EPS (Diluted)
$2.43
was $1.19
Earnings per share rose 104% — each share earned more.
Gross Profit
$512.5M
was $399.9M
Gross profit rose 28% — the spread between revenue and direct costs improved.
Revenue
$1.5B
was $1.3B
Revenue grew 17% — the company sold more goods or services than the prior year.
Operating Cash Flow
$69.0M
was $80.1M
Operating cash flow fell 14% but remained positive.
Risk Flags
0 high · 1 medium · 0 low- ◈ Medium
Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.
Technical Signals
Daily closes · 1-year dataPhibro Animal Health Corporation: common questions
Is Phibro Animal Health Corporation profitable?
Yes. Phibro Animal Health Corporation made a net profit of $100M in its latest fiscal year (fiscal 2026), a net margin of 6.6%.
Is Phibro Animal Health Corporation's revenue growing?
Yes. Revenue grew 17.1% year on year, to $1.5B.
What is Phibro Animal Health Corporation's P/E ratio?
Phibro Animal Health Corporation trades at 13.3× its trailing twelve-month earnings. In other words, the share price is about 13 times the profit per share the company earned over the past year.
Does Phibro Animal Health Corporation pay a dividend?
Yes. Phibro Animal Health Corporation's forward dividend yield is 1.44%, the expected annual dividend as a share of the current share price.
What are the main risks for Phibro Animal Health Corporation?
Fisclear's checks flag 1 medium- or high-severity risk. The most serious: Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.
Answers are generated from the figures in this report (updated 5 Nov 2026). Information, not investment advice.
Latest News
via FinnhubFiling History — PAHC
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade PAHC
Links open broker research pages. Not an endorsement or recommendation.
Research Phibro Animal Health Corporation
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.